Self-assembled peptide nanoparticles as tumor microenvironment activatable probes for tumor targeting and imaging.

Design of specific and sensitive imaging probes for targeting tumor microenvironment holds great promise to achieve precise detection and rapid responsiveness to neoplastic tissues. Dysregulated pH, one of the most remarkable hallmarks of tumor microenvironment, can be considered as a good specific trigger for the design of broad-spectrum and local-environment responsive imaging probes. However, the current existing design strategies for pH-responsive systems are insufficient to meet the needs for a rapid and tumor-specific diagnosis. Here we reported a novel biomimetic nanostructure based on oligopeptide self-assembly that can quickly switch into dissociated stage with active fluorescence property from self-assembled stage with quenched fluorescence activity when encountering a subtle pH-change in tumor microenvironment (pH 6.8 vs. 7.4). This oligopeptide-assembly is examined as tumor microenvironment activatable probes for both intratumoral and intravenous in vivo tumor imaging. Through the distinct fluorescent intensities, it is validated that the acidic tumor microenvironment can activate stronger fluorescence signals. The tailor-made self-assembled oligopeptide nanomaterials have the potential for efficient and specific in situ diagnosis of various solid tumors with a weakly acidic microenvironment, which is expected to be of crucial importance for clinical tumor diagnostics.

[1]  Jin-Zhi Du,et al.  Tailor-made dual pH-sensitive polymer-doxorubicin nanoparticles for efficient anticancer drug delivery. , 2011, Journal of the American Chemical Society.

[2]  T. Tan,et al.  Self-assembling peptide nanofiber scaffolds for controlled release governed by gelator design and guest size. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[3]  Eun Seong Lee,et al.  A smart polysaccharide/drug conjugate for photodynamic therapy. , 2011, Angewandte Chemie.

[4]  M. Dewhirst,et al.  Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers. , 2006, Journal of the National Cancer Institute.

[5]  Elise C. Kohn,et al.  The microenvironment of the tumour–host interface , 2001, Nature.

[6]  Daniel A. Heller,et al.  Treating metastatic cancer with nanotechnology , 2011, Nature Reviews Cancer.

[7]  Omid C Farokhzad,et al.  Targeted polymeric therapeutic nanoparticles: design, development and clinical translation. , 2012, Chemical Society reviews.

[8]  Byron Ballou,et al.  Fluorescence imaging of tumors in vivo. , 2005, Current medicinal chemistry.

[9]  Balaji Narasimhan,et al.  Multifunctional nanoparticles for targeted delivery of immune activating and cancer therapeutic agents. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[10]  Ashutosh Chilkoti,et al.  Triple stimulus-responsive polypeptide nanoparticles that enhance intratumoral spatial distribution. , 2012, Nano letters.

[11]  S. Achilefu,et al.  Near-infrared pH-activatable fluorescent probes for imaging primary and metastatic breast tumors. , 2011, Bioconjugate chemistry.

[12]  Y. Yoshioka,et al.  Design of a pH-Sensitive Polymeric Carrier for Drug Release and Its Application in Cancer Therapy , 2004, Clinical Cancer Research.

[13]  Jinming Gao,et al.  Tunable, ultrasensitive pH-responsive nanoparticles targeting specific endocytic organelles in living cells. , 2011, Angewandte Chemie.

[14]  Kwangmeyung Kim,et al.  Hybrid ferritin nanoparticles as activatable probes for tumor imaging. , 2011, Angewandte Chemie.

[15]  Eun Seong Lee,et al.  3-Diethylaminopropyl-bearing glycol chitosan as a protein drug carrier. , 2011, Colloids and surfaces. B, Biointerfaces.

[16]  Y. Tseng,et al.  Repeated rapid shear-responsiveness of peptide hydrogels with tunable shear modulus. , 2005, Biomacromolecules.

[17]  Eun Seong Lee,et al.  A charge-switched nano-sized polymeric carrier for protein delivery. , 2010, International journal of pharmaceutics.

[18]  Jin-Zhi Du,et al.  A tumor-acidity-activated charge-conversional nanogel as an intelligent vehicle for promoted tumoral-cell uptake and drug delivery. , 2010, Angewandte Chemie.

[19]  Ick Chan Kwon,et al.  pH-Sensitive nanoflash for tumoral acidic pH imaging in live animals. , 2010, Small.

[20]  Darren H. Wakefield,et al.  Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytes , 2007, Proceedings of the National Academy of Sciences.

[21]  M. Roizen,et al.  Hallmarks of Cancer: The Next Generation , 2012 .

[22]  R. Jain,et al.  Delivery of molecular and cellular medicine to solid tumors. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[23]  Eun Seong Lee,et al.  A smart flower-like polymeric micelle for pH-triggered anticancer drug release. , 2009, International journal of pharmaceutics.

[24]  Igor L. Medintz,et al.  Hydrodynamic dimensions, electrophoretic mobility, and stability of hydrophilic quantum dots. , 2006, The journal of physical chemistry. B.

[25]  Shuguang Zhang Fabrication of novel biomaterials through molecular self-assembly , 2003, Nature Biotechnology.

[26]  J. Lu,et al.  Molecular self-assembly and applications of designer peptide amphiphiles. , 2010, Chemical Society reviews.

[27]  J. Koenderink Q… , 2014, Les noms officiels des communes de Wallonie, de Bruxelles-Capitale et de la communaute germanophone.

[28]  Véronique Préat,et al.  To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[29]  U. Rodeck,et al.  Regulation of intracellular pH in human melanoma: potential therapeutic implications. , 2002, Molecular cancer therapeutics.

[30]  D. Auguste,et al.  Nanocarrier cross-linking density and pH sensitivity regulate intracellular gene transfer. , 2009, Nano letters.

[31]  S. Gambhir,et al.  Quantum Dots for Live Cells, in Vivo Imaging, and Diagnostics , 2005, Science.

[32]  Mauro Ferrari,et al.  Multistage nanovectors: from concept to novel imaging contrast agents and therapeutics. , 2011, Accounts of chemical research.

[33]  S. Nie,et al.  Nanotechnology applications in cancer. , 2007, Annual review of biomedical engineering.

[34]  R. Hill,et al.  Glucose starvation and acidosis: effect on experimental metastatic potential, DNA content and MTX resistance of murine tumour cells. , 1991, British Journal of Cancer.

[35]  Jin-Zhi Du,et al.  Sheddable ternary nanoparticles for tumor acidity-targeted siRNA delivery. , 2012, ACS nano.

[36]  Omid C Farokhzad,et al.  pH-Responsive nanoparticles for drug delivery. , 2010, Molecular pharmaceutics.

[37]  T. Kinoshita,et al.  Polypeptide membranes at an interface , 2003 .

[38]  Matthew P. Jacobson,et al.  Dysregulated pH: a perfect storm for cancer progression , 2011, Nature Reviews Cancer.

[39]  Fan Zhang,et al.  Chimeric ferritin nanocages for multiple function loading and multimodal imaging. , 2011, Nano letters.

[40]  Pedro M. Valencia,et al.  Targeted Polymeric Therapeutic Nanoparticles: Design, Development and Clinical Translation , 2012 .

[41]  Ashutosh Chilkoti,et al.  Self-assembling chimeric polypeptide-doxorubicin conjugate nanoparticles that abolish tumors after a single injection , 2009, Nature materials.

[42]  T. Tan,et al.  Nanofibrous scaffold from self-assembly of beta-sheet peptides containing phenylalanine for controlled release. , 2010, Journal of controlled release : official journal of the Controlled Release Society.